Nikki Haley claims her mother denied judgeship in India for being woman

March 30, 2017

New York, Mar 30: US' Permanent Representative to the United Nations Nikki Haley claimed on Wednesday that her mother was not allowed to be a judge in India because she was a woman.

Responding to a question regarding the role of women at a meeting of the Council on Foreign Relations, Haley said, "When you didn`t have a lot of education in India, my mother actually was able to go to law school. And she was actually put up to be one of the first female judges in India, but because of the situation with women she wasn`t allowed to sit on the bench."

"But how amazing for her to watch her daughter become governor of South Carolina and US ambassador to the UN," she added.

However, it is to be noted that women have been judges in India since at least 1937.

Haley`s parents, Ajit Singh and Raj Kaur Randhawa, reportedly emigrated from India in the 1960s. Raj Kaur Randhawa studied Law at the University of Delhi. But more than two decades earlier a woman, Anna Chandy, had become a judge in Travancore in pre-Independence India.

Chandy was promoted to District Judge in 1948, the year after Independence, and became a High Court judge in 1959. Chandy was able to sit on the bench and function as a judge all through -- years before Haley`s parents left India.

UN Ambassador is a cabinet-level position in the US and Haley is the first Indian-American to reach that position. A Republican, she was the elected Governor of South Carolina state in 2010.

Comments

Add new comment

Coastaldigest.com reserves the right to delete or block any comments.
Coastaldigset.com is not responsible for its readers’ comments.
Comments that are abusive, incendiary or irrelevant are strictly prohibited.
Please use a genuine email ID and provide your name to avoid reject.

AstraZeneca to withdraw Covid-19 vaccine globally as demand dips after admitting side effects

News Network

May 8,2024

AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.

The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.

"As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.

According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.

The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.

London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.

Comments